← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Alexion Pharmaceuticals, Inc.
Cheshire, CT
$3,251,731
Total funding
3
Grants
Funding over time
peak $1.5M · FY2005–06$2M$1.5M$1M$500K$0
'05
'06
Funding mix
By agency
NIH$3,251,731 · 3
By mechanism
U01$2,559,731 · 1
R43$692,000 · 2
Investigators at Alexion Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Human Antibody Therapeutics Against Anthrax$1,194,683
U01 · FY2006 · AI
Human Antibody Therapeutics Against Anthrax$737,620
U01 · FY2004 · AI
Human Antibody Therapeutics Against Anthrax$627,428
U01 · FY2005 · AI
Nebulizing Eculizumab for intrapulmonary C5 inhibition$297,000
R43 · FY2005 · AI
Nebulizing Eculizumab for intrapulmonary C5 inhibition$295,000
R43 · FY2006 · AI
PREVENTION OF TYPE I DIABETES BY FUSION PROTEINS$100,000
R43 · FY2000 · DK